Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,847.00    0.00 (0.00%)
Bid:
1,857.00
Ask:
1,859.00
Spread: 2.00 (0.108%)
Market Cap: £5.90b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Director/PDMR Shareholding

3 Aug 2016 18:12

RNS Number : 1936G
Hiscox Ltd
03 August 2016
 

 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMR')

 

 

Hamilton, Bermuda - The Company has been notified by Mr Richard Watson, a Director, that on 2 August 2016 he exercised nil-cost options under the Performance Share Plan to acquire 134,837 Ordinary Shares of 6.5p per share ("Shares"). On the same date Mr Watson sold 96,234 Shares at a price of 1083.862p per share. The transactions were executed in GBP. The notification made in accordance with the requirements of the EU Market Abuse Regulation (EU 596/2014) is set out below.

 

Following these transactions Mr Watson remains interested in 750,000 Ordinary Shares.

 

Jeremy Pinchin

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Richard Watson

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director and Chief Underwriting Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Hiscox Ltd

b)

 

LEI

 

 

5493007JXOLJ0QCY2D70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

 

b)

 

Nature of the transaction

 

 

Exercise of options under the Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil cost options

 

134,837

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

134,837

 

 

Nil cost options

 

 

e)

 

Date of the transaction

 

 

2 August 2016

f)

 

Place of the transaction

 

 

Outside a trading venue

5

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

 

b)

 

Nature of the transaction

 

 

Sale of Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1083.86230438p

 

96,234

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

96,234

 

 

£1,043,044.05 (aggregate price)

 

e)

 

Date of the transaction

 

 

2 August 2016

f)

 

Place of the transaction

 

 

XLON

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBLGDILSGBGLX
Date   Source Headline
27th Jan 202111:21 amRNSTR-1:Standard form-notification major shareholding
15th Jan 202110:40 amRNSHiscox Ltd response to Supreme Court Judgment
11th Jan 20211:01 pmRNSDirector/PDMR Shareholding
4th Jan 202112:36 pmRNSTotal Voting Rights
1st Dec 202011:56 amRNSTotal Voting Rights
26th Nov 202011:40 amRNSDirector/PDMR Shareholding
6th Nov 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20207:00 amRNSHiscox Ltd trading statement
12th Oct 202011:22 amRNSTR-1: Standard form-notification of major holdings
1st Oct 202011:48 amRNSTotal Voting Rights
1st Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Sep 20207:13 amRNSUpdate on UK Insurance Industry Test Case
16th Sep 202011:54 amRNSNotification of transactions by PDMR
15th Sep 202011:25 amRNSResponse to Insurance Industry Test Case Judgment
14th Sep 20204:35 pmRNS2021 Syndicate Business Forecast
7th Aug 20207:00 amRNSCorrection: Syndicate results and estimates
3rd Aug 20207:01 amRNSHiscox Ltd interim results
3rd Aug 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
22nd Jun 20205:27 pmRNSTR-1: Standard form-notification of major holdings
19th Jun 202012:19 pmRNSRights Attaching to Equity Shares
9th Jun 20204:27 pmRNSTR-1: Standard form-notification of major holdings
3rd Jun 202012:03 pmRNSTR-1: Standard form-notification of major holdings
1st Jun 20201:27 pmRNSTotal Voting Rights
1st Jun 20207:35 amRNSHiscox Ltd response to FCA announcement
28th May 20203:23 pmRNSTR-1: Standard form-notification of major holdings
20th May 20204:21 pmRNSTR-1: Standard form-notification of major holdings
20th May 202012:03 pmRNSDirector / PDMR Shareholding
19th May 202012:09 pmRNSDirector Declaration
18th May 20202:58 pmRNSTR-1: Standard form-notification of major holdings
15th May 20207:00 amRNSAGM Results
14th May 20202:06 pmRNSDirector/PDMR Shareholding
13th May 20204:20 pmRNSTR-1: Standard form-notification of major holdings
13th May 20208:53 amRNSTR-1: Standard form-notification of major holdings
11th May 20202:40 pmRNSTR-1: Standard form-notification of major holdings
6th May 20205:30 pmRNSHiscox
6th May 20207:00 amRNSResults of capital raise
5th May 20204:35 pmRNSHiscox Ltd trading statement
5th May 20204:35 pmRNSProposed capital raise of ordinary shares
4th May 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
1st May 202012:29 pmRNSTotal Voting Rights
29th Apr 20207:00 amRNSResponse to press speculation
22nd Apr 20207:00 amRNSMarket update on COVID-19 exposure
15th Apr 20202:20 pmRNSMarket update re business interruption exposure
14th Apr 20202:38 pmRNSNotice of 2020 Annual General Meeting
8th Apr 20207:00 amRNSUpdate on dividend payment and guidance
1st Apr 202012:07 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20201:08 pmRNSDirector/PDMR Shareholding
11th Mar 20202:36 pmRNSAnnual Report
5th Mar 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.